MicroRNA-338-3p inhibits colorectal carcinoma cell invasion and migration by targeting smoothened

Japanese Journal of Clinical Oncology

Volumn 44, Issue 1, 2014, Pages 13-21

  Xue, Qi ^a   Sun, Kai ^a   Deng, Hai Jun ^a   Lei, Shang Tong ^a   Dong, Jing Qing ^a   Li, Guo Xin ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Colorectal carcinoma; Hsa miR 338 3p; Invasion; Migration; Smoothened

Indexed keywords

MICRORNA; MICRORNA 338 3P; SMALL INTERFERING RNA; SMOOTHENED PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER STAGING; CARCINOMA CELL; CELL INVASION; CELL MIGRATION; CLINICAL ARTICLE; COLORECTAL CARCINOMA; COMPARATIVE STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MALE; MIDDLE AGED; REGULATORY MECHANISM; TUMOR INVASION; UPREGULATION;

EID: 84892468630     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyt181     Document Type: Article

References (27)

1. Sun K, Deng HJ, Lei ST, Dong JQ, Li GX. miRNA-338-3p suppresses cell growth of human colorectal carcinoma by targeting smoothened. World J Gastroenterol 2013;19:2197-207.
2. Fabbri M. MiRNAs as molecular biomarkers of cancer. Expert Rev Mol Diagn 2010;10:435-44.
3. Foersch S, Waldner MJ, Neurath MF. Colitis and colorectal cancer. Dig Dis 2012;30:469-76.
4. Schetter AJ, Okayama H, Harris CC. The role of microRNAs in colorectal cancer. Cancer J 2012;18:244-52.
5. Drebber U, Lay M, Wedemeyer I, et al. Altered levels of the onco-microRNA 21 and the tumor-suppressor microRNAs 143 and 145 in advanced rectal cancer indicate successful neoadjuvant chemoradiotherapy. Int J Oncol 2011;39:409-15.
6. Altomare DF, Di Lena M, Giuratrabocchetta S. MicroRNA: future perspectives in colorectal cancer. Colorectal Dis 2012;14:133-4.
7. Hogan NM, Joyce MR, Kerin MJ. MicroRNA expression in colorectal cancer. Cancer Biomark 2012;11:239-43.
8. Ju J. miRNAs as biomarkers in colorectal cancer diagnosis and prognosis. Bioanalysis 2010;2:901-6.
9. Reichel M, Li J, Millar AA. Silencing the silencer: strategies to inhibit microRNA activity. Biotechnol Lett 2011;33:1285-92.
10. Mosakhani N, Sarhadi VK, Borze I, et al. MicroRNA profiling differentiates colorectal cancer according to KRAS status. Genes Chromosomes Cancer 2012;51:1-9.
11. Aschrafi A, Schwechter AD, Mameza MG, Natera-Naranjo O, Gioio AE, Kaplan BB. MicroRNA-338 regulates local cytochrome c oxidase IV mRNA levels and oxidative phosphorylation in the axons of sympathetic neurons. J Neurosci 2008;28:12581-90.
12. Luo Y, Zhang S. Computational prediction of amphioxus microRNA genes and their targets. Gene 2009;428:41-6.
13. Yang B, Sun HY, Chen WH, Wen JL, Shi XT, Wang YM. Lentivirusmediated SMO RNA interference inhibits SMO expression and cell proliferation, and affects the cell cycle in LNCaP and PC3 cancer cell lines. Asian J Androl 2010;12:196-202.
14. Wang K, Pan L, Che X, et al. Sonic Hedgehog/GLI signaling pathway inhibition restricts cell migration and invasion in human gliomas. Neurol Res 2010;32:975-80.
15. Uchida H, Arita K, Yunoue S, et al. Role of sonic hedgehog signaling in migration of cell lines established from CD133-positive malignant glioma cells. J Neurooncol 2011;104:697-704.
16. Sun K, Guo C, Deng HJ, Dong JQ, Lei ST, Li GX. Construction of lentivirus-based inhibitor of hsa-microRNA-338-3p with specific secondary structure. Acta Pharmacol Sin 2013;34:167-75.
17. Lin M, Chen W, Huang J, et al. MicroRNA expression profiles in human colorectal cancers with liver metastases. Oncol Rep 2011;25:739-47.
18. Sun K, Wang W, Zeng JJ, Wu CT, Lei ST, Li GX. MicroRNA-221 inhibits CDKN1C/p57 expression in human colorectal carcinoma. Acta Pharmacol Sin 2011;32:375-84.
19. Kong W, Yang H, He L, et al. MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA. Mol Cell Biol 2008;28:6773-84.
20. Gregory PA, Bert AG, Paterson EL, et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 2008;10:593-601.
21. Crawford M, Brawner E, Batte K, et al. MicroRNA-126 inhibits invasion in non-small cell lung carcinoma cell lines. Biochem Biophys Res Commun 2008;373:607-12.
22. Sengupta S, den Boon JA, Chen IH, et al. MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins. Proc Natl Acad Sci USA 2008;105:5874-8.
23. Huang XH, Wang Q, Chen JS, et al. Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated. Hepatol Res 2009;39:786-94.
24. Xu M, Li X, Liu T, Leng A, Zhang G. Prognostic value of hedgehog signaling pathway in patients with colon cancer. Med Oncol 2012;29:1010-6.
25. Mazumdar T, DeVecchio J, Shi T, Jones J, Agyeman A, Houghton JA. Hedgehog signaling drives cellular survival in human colon carcinoma cells. Cancer Res 2011;71:1092-102.
26. Mazumdar T, Devecchio J, Agyeman A, Shi T, Houghton JA. Blocking Hedgehog survival signaling at the level of the GLI genes induces DNA damage and extensive cell death in human colon carcinoma cells. Cancer Res 2011;71:5904-14.
27. Huang XH, Chen JS, Wang Q, et al. miR-338-3p suppresses invasion of liver cancer cell by targeting smoothened. J Pathol 2011;225:463-72.